Novartis Ag (NVS) Shares Outstanding (Diluted Average) (2009 - 2026)
Novartis Ag recorded quarterly Shares Outstanding (Diluted Average) of $1.6 million in Q1 2026, down 76.92% quarter-over-quarter from $7.2 million in Q4 2025, and down 9.34% year-over-year from $1.8 million in Q1 2025.
Novartis Ag's Shares Outstanding (Diluted Average) history runs 18 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) fell 9.34% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (down 9.34% YoY), while the FY2025 annual figure was $7.2 million, up 21.81% from the prior year.
- Shares Outstanding (Diluted Average) came in at $1.6 million for Q1 2026 at Novartis Ag, down from $7.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $7.2 million in Q4 2025 to a low of $990000.0 in Q1 2022.
- A 5-year average of $3.0 million and a median of $2.8 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
- Across the five-year window, Shares Outstanding (Diluted Average) sank 74.13% in 2022 and soared 165.14% in 2024, its largest moves.
- Novartis Ag's Shares Outstanding (Diluted Average) stood at $2.8 million in 2022, then jumped by 49.09% to $4.1 million in 2023, then soared by 43.17% to $5.9 million in 2024, then advanced by 21.81% to $7.2 million in 2025, then sank by 76.92% to $1.6 million in 2026.
- According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $1.6 million, $7.2 million, and $5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | 1.65 Mn |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 895.90 Mn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 2.45 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 1.77 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | - |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 1.25 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 5.73 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | - |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.65 Mn |
| Dec 31, 2025 | 7.15 Mn |
| Sep 30, 2025 | 5.90 Mn |
| Jun 30, 2025 | 3.88 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Dec 31, 2024 | 5.87 Mn |
| Sep 30, 2024 | 4.46 Mn |
| Jun 30, 2024 | 2.89 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 4.10 Mn |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 2.75 Mn |
| Sep 30, 2022 | 2.14 Mn |
| Jun 30, 2022 | 1.76 Mn |
| Mar 31, 2022 | 990,000.00 |
| Dec 31, 2021 | 10.63 Mn |
| Sep 30, 2021 | 3.41 Mn |
| Jun 30, 2021 | 2.19 Mn |
| Mar 31, 2021 | 910,000.00 |
| Dec 31, 2020 | 3.52 Mn |
| Sep 30, 2020 | 2.60 Mn |
| Jun 30, 2020 | 1.76 Mn |
| Mar 31, 2020 | 950,000.00 |
| Dec 31, 2019 | 3.08 Mn |
| Sep 30, 2019 | 2.59 Mn |
| Jun 30, 2019 | 900,000.00 |
| Mar 31, 2019 | 760,000.00 |
| Dec 31, 2018 | 5.38 Mn |
| Sep 30, 2018 | 4.87 Mn |
| Jun 30, 2018 | 3.29 Mn |
| Mar 31, 2018 | 840,000.00 |
| Dec 31, 2017 | 3.25 Mn |
| Sep 30, 2017 | 2.41 Mn |
| Jun 30, 2017 | 830,000.00 |
| Mar 31, 2017 | 700,000.00 |
| Dec 31, 2016 | 2.40 Bn |
| Sep 30, 2016 | 2.40 Mn |
| Jun 30, 2016 | 750,000.00 |
| Mar 31, 2016 | 840,000.00 |
| Dec 31, 2015 | 2.88 Mn |
| Sep 30, 2015 | 2.44 Mn |
| Jun 30, 2015 | 750,000.00 |
| Mar 31, 2015 | 940,000.00 |
| Dec 31, 2014 | 4.31 Mn |
| Sep 30, 2014 | 3.32 Mn |
| Jun 30, 2014 | 1.03 Mn |
| Mar 31, 2014 | 970,000.00 |
| Dec 31, 2013 | 3.70 Mn |
| Sep 30, 2013 | 900,000.00 |
| Jun 30, 2013 | 1.01 Mn |
| Mar 31, 2013 | 970,000.00 |
| Sep 30, 2012 | 3.06 Mn |
| Jun 30, 2012 | 2.05 Mn |
| Mar 31, 2012 | 950,000.00 |
| Dec 31, 2011 | 3.78 Mn |
| Sep 30, 2011 | 3.30 Mn |
| Jun 30, 2011 | 1.11 Mn |
| Mar 31, 2011 | 1.20 Mn |
| Dec 31, 2010 | 4.26 Mn |
| Sep 30, 2010 | 3.32 Mn |
| Jun 30, 2010 | 1.05 Mn |
| Mar 31, 2010 | 1.28 Mn |
| Dec 31, 2009 | 3.69 Mn |
| Sep 30, 2009 | 2.67 Mn |
| Jun 30, 2009 | 890,000.00 |
| Mar 31, 2009 | 860,000.00 |